Skip to main content
. 2018 Feb 13;9:92. doi: 10.3389/fphar.2018.00092

FIGURE 7.

FIGURE 7

Schematic diagram shows scutellarin increases the sensitivity of non-small cell lung cancer to cisplatin via ERK/p53 and c-met/AKT signaling pathways.